Blue Horseshoe Stocks: DMPI Recap & More

Del Mar Pharmaceuticals, Inc . DMPI

We wanted to swing back around to recap the solid performance of DMPI since we tagged it the day after the Christmas break a couple of weeks back.

It was just a couple sessions later that the stock would find support at .96, and begin a pretty substantial run up the chart. It was helped along by the last six consecutive sessions registering higher base levels of support as the stock has crept all the way up to a high of 1.75, recorded on Friday.

That worked out to a move of 82% in less than two trading weeks, while volume over the same period has been heightened. The high coincided with the current 200DMA, so we’ll look for DMPI to possibly crack that 1.75 mark and head for blue skies.



Kohls Corp KSS

We want to include an options idea for Kohls as we kick off the first full trading week of 2018, on the heels of a solid earnings report.

The company posted strong sales for the holiday season, while giving a significant boost to full year guidance. Shares jumped accordingly in premarket trading, and we are going to be waiting with some targeted weekly contracts to coincide with the activity. We’re going to signal and track the KSS Weekly $58-60 Calls.


Extended Watchlist:
STX, UEPS, ARGS, SDRL, VRAY, NTEC, IMNP, KBSF

Blue Horseshoe Stocks: Kicking Off the Short Week

INSYS Therapeutics, Inc. INSY

This morning we kick off the holiday shortened week, during a time of year that typically sees subdued activity for the markets as a whole, as people spend time with their families, and stay busy with holiday festivities.

We still strive to identify possible opportunities even in this environment, and the first thing to hit our scanner this morning was INSY. INSYS Therapeutics recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy.

The FDA, we’re learning today, has also granted Fast Track status to INSY for the ‘drug’ for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. (View PR)

The stock registered its 52-week lows at the beginning of last month, and has been in a general uptrend since, but we’ll be looking for further bullish activity on the heels of this FDA news, both on the stock chart, and in the options chain as a secondary idea. For that, we’ll look to the INSY 01/19 $8 & $9 Calls for opportunities.


DelMar Pharmaceuticals, Inc. DMPI

Speaking of FDA Fast Track designations, we’re looking to DMPI this morning as well, which was granted the status by the FDA for its lead-product cancer treatment, VAL-083.

The chart itself was already set up as a possible bottom play, and despite gapping up considerably on this morning’s news, there is still room to the upside, including a sizable gap that’s been left on the chart since this past spring, the eventual filling of which would spell gains of more than 100% from the current PPS.


Extended Watchlist:
KLXI, EXXI, AEZS, SRAX, IMUC, NETE

Blue Horseshoe Stocks: Fresh Options Plays & More

Options Roundup

Yesterday, we took the opportunity to update readers on the performances of some successful stock calls we made recently. Today we want to turn back to the options trading front with a couple updates on longer-term calls we’ve made, as well as a fresh idea. 

Chipotle Mexican Grill, Inc. CMG - Beginning with the new idea, we we’re noticing a good chart setup on Chipotle, with a number of factors pointing to potential bullish activity forthcoming.  We’d like to signal a range of contracts to watch accordingly. We’ll have our eye on the CMG Weekly $297.50-305 Calls.
________

Verizon Communications, Inc. VZ -  We highlighted a range of calls in the Verizon chain a couple of Fridays ago, and the stock has been on an impressive uptrend ever since. We want to provide updated figures, on the total possible gains we’ve witnessed since putting the VZ 01/19 $45-48 Calls on watch.

$45 Calls – Range: 1.08 -3.95 – Max Gain: 266%
$46 Calls – Range: .59-3.06 – Max Gain: 419%
$47 Calls – Range: .39-2.25 – Max Gain: 477%
$48 Calls – Range: .23-1.55 – Max Gain: 574%

_________

AT&T, Inc. ATT
-  We also recently signaled a range of  ATT calls (Nov 9th) on a longer term basis, the ATT 01/19 $34-36 Calls, and those ranges have increased as well, with a bullish performance from T continuing over the past few weeks.

$34 Calls
– Range: .91-1.81 – Max Gain: 99%
$35 Calls – Range: .53-1.12 – Max Gain: 111%
$36 Calls – Range: 37-.66 – Max Gain: 78%


Extended Watchlist:

SINO, DPW, RAD, DMPI, GROW, PZRX,

Blue Horseshoe Stocks: DE Options Recap & More

Urban Outfitters, Inc. URBN – Options Rehash

We have been hitting one home run after another with our options ideas recently, and kept the trend going on Wednesday before the holiday break. We offered up the Deere & Co. DE Weekly $143-146 Calls as a fresh idea for the day in our premarket report, and it turned out to be another good one.

All but one of the contracts contained within our highlighted range recorded single-session gains exceeding two hundred percent!

DE Weekly $143-146 Calls
$143 Calls –
Range:  .82-2.50 – Max Gain: 205%
$144 Calls – Range:  .50-1.53 – Max Gain: 206%
$145 Calls – Range:  .30-1.00 – Max Gain: 233%
$146 Calls – Range: .19-.53 – Max Gain: 220%

From the looks of things this morning , we could actually end up seeing these ranges extended even further. Just be aware that the normal extreme risk associated with trading weekly options on a Friday is heightened even more in a half-day scenario like today.


General Electric Co. GE – More Options Ideas

We’ve been watching GE try to find a bottom for more than a month now, and finally, we’ve got a coupls solid signals that this could be the moment we were waiting for. Not only did the stock make a moderate rebound off of its newly-registered 52-week lows, but we’ve also noticed an enormous tranche of insider buying.

An order for 3M shares was executed earlier this week in the amount of roughly $53M. You don’t generally tend to see that kind of money sunk into a stock by someone in-the-know, unless they’re fairly certain that the current support will hold.

As a result, we are going to signal a range of options ideas here as well for a longer-term recovery play, with the targets being the GE 01/19 $18-19 Calls.


Extended Watchlist:
MARK, CLSN, UEPS, DMPI, SSC, SCZ, SD, PLX

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

We took notice of ECYT yesterday morning during our routine premarket scan, and due to some abnormal activity, we decided to include it in the daily watchlist.

It turned out to be a splendid idea, with the stock ultimately recording a hugely bullish session. ECYT traded from its low of 1.63 just following the open, to its high of 3.75 just prior to the close. It worked out to a single-session rip of 130% and it came on over 180X the monthly average volume. The stock has also hit a new high of 6.07 in the premarket this morning, pushing our observed move in less than 24 hours to a whopping 272%

It was especially impressive because of the timing, which couldn’t have been any better. Prior to yesterday’s session the stock was stagnating for several months. The move was catalyzed primarily by the announcement of the completion of a worldwide license on the company’s prostate cancer treatment, which will be moving on to Phase III development. (>>View PR)


Rigel Pharmaceuticals, Inc. RIGL

Speaking of solidly-timed calls on pharma plays, we also caught RIGL and included it in yesterday’s premarket report. It didn’t see the type of move that the previously mentioned stock, but got off to a respectable start.

RIGL traded in a range from 2.85-3.42, a modest rise of 20%, but did so on nearly 17X the monthly average volume, and closed near its high of day. We’ll continue to observe this play to see if it can establish a sustained uptrend.


Capricor Therapeutics, Inc. CAPR

We were just updating our readers yesterday morning on the moves CAPR had made since we had alerted it onSeptember 20th from its low of 1.80.

What followed was another nice session for the stock, which ran to a new high of 4.25; a total increase of 136% in a span of just eight trading days.



Tiffany & Co. TIF – Options Update

We also want to quickly update readers on our TIF options ideas that we submitted on the morning of September 28th, the TIF 10/20 $92-93 Calls. The stock has been in a continuous bullish pattern since then, and those calls made some pretty nice gains in the process.

$92 Calls – Range: 1.00-2.13 – Max Gain: 113%
$92.50 Calls – Range: .85-1.74  – Max Gain: 105%.
$93 Calls – Range: .83-1.88 – Max Gain: 127%


Extended Watchlist:
ETRM, VICL, DMPI, TA, KOOL, CATB